The Business Research Company’s Psoriasis
Drugs Market covers market characteristics, size and growth,
segmentation, regional and country breakdowns, competitive landscape, market
shares, trends and strategies for this market.
The psoriasis drugs market
consists of sales of psoriasis drugs. Psoriasis is a persistent skin disorder
which causes distress and pain through patches of abnormal skin. Psoriasis can
be caused due to injuries to skin, medications, genetics, infection, diet,
weather, etc. The drugs vary depending on the severity of the infection and provide
relief from infections. Examples of drugs in the psoriasis market include
Clobetasol (Temovate), triamcinolone (Aristocort), fluocinolone (Synalar), and
betamethasone (Diprolene).
Major players in the market are AbbVie Inc., Pfizer Inc., Novartis, Eli Lilly
and Company and Celgene Corporation.
The rise in the prevalence of
psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to
immune system, genetics and environment. The rise in psoriasis patients in the
past few years can be mainly attributed to climate change, stress and unhealthy
lifestyle. According to the World Health Organization (WHO), psoriasis had
affected at least 100 million individuals worldwide in 2016.
The high cost of psoriasis
therapy is a restraint for the psoriasis market. According to a study conducted
by JAMA Dermatology in 2019, the typical psoriasis treatments with biologics
are very costly, ranging between $10,000 and $25,000 per year. The high cost is
because patent protections are preventing many alternative drugs.
View complete Report: https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
The high cost of psoriasis
therapy is a restraint for the psoriasis market. According to a study conducted
by JAMA Dermatology in 2019, the typical psoriasis treatments with biologics
are very costly, ranging between $10,000 and $25,000 per year. The high cost is
because patent protections are preventing many alternative drugs.
North America was the largest
region in the psoriasis drugs market in 2018. This region is expected to remain
the largest during the next five years. The psoriasis drugs market in Asia Pacific
is forecasted to register the highest CAGR during 2018-2023.
Browse Year End
Discounted Reports Offered By TBRC @ https://www.thebusinessresearchcompany.com/discounted-reports.aspx
About Us:
The Business Research Company is a Business Intelligence
Company which excels in company, market and consumer research. It has offices
in the UK, the US and India and a network of trained researchers in 15
countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
View Our Latest Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
